In Vitro Validation of Survivin as Target Tumor-associated Antigen for Immunotherapy in Uterine Cancer

Anke Vanderstraeten, Tina Everaert, Rieta Van Bree, Godelieve Verbist, Catherine Luyten, Frederic Amant, Sandra Tuyaerts

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)239-249
Number of pages11
JournalJournal of Immunotherapy
Volume38
Issue number6
DOIs
Publication statusPublished - 2015

Keywords

  • uterine cancer
  • survivin
  • tumor-associated antigen
  • immunogenicity
  • spontaneous immune responses

Cite this